Shares of Athenex Inc. soared in their public debut Wednesday, as they traded 16% above their initial-public-offering price in afternoon trade. The biopharmaceutical company's stock first traded on the Nasdaq exchange at $12.00, or 9.1% above its IPO price of $11.00, at 11:15 a.m. ET. It traded as low as $11.21 at about 11:24 a.m., and as high as $13.00 at 3:44 p.m., before paring some gains. The company raised $66 million in its IPO.
Copyright © 2017 MarketWatch, Inc.